Phase Forward to Present at the 18th Annual Credit Suisse Healthcare Conference
November 04 2009 - 8:30AM
Business Wire
Phase Forward (NASDAQ: PFWD), a leading provider of data
management solutions for clinical trials and drug safety, today
announced its senior vice president and chief financial officer,
Chris Menard, and senior vice president of integration and product
strategy, Martin Young, will present at the 18th Annual Credit
Suisse Healthcare Conference at the Arizona Biltmore Hotel in
Phoenix, Arizona.
The Phase Forward presentation is scheduled for Wednesday,
November 11, 2009 at 8:00 a.m. MT. The presentation will be webcast
live and will be available by visiting the Investors section of the
company’s website at www.phaseforward.com. The webcast will be
archived on the company’s website for 30 days after the conference
ends.
About Phase Forward
Phase Forward is a leading provider of integrated data
management solutions for clinical trials and drug safety. Phase
Forward’s products and services have been utilized in over 10,000
clinical trials involving more than 1,000,000 clinical trial study
participants at over 300 organizations and regulatory agencies
worldwide including: AstraZeneca, Boston Scientific, Dana-Farber
Cancer Institute, Eli Lilly, the U.S. Food and Drug Administration,
GlaxoSmithKline, Harvard Clinical Research Institute, Merck Serono,
Novartis, Novo Nordisk, PAREXEL International, Procter &
Gamble, Quintiles, sanofi-aventis, Schering-Plough Research
Institute, Servier, SGS, Tibotec and the U.K. Medicines and
Healthcare Products Regulatory Agency. Additional information about
Phase Forward is available at www.phaseforward.com.
Phase Forward (NASDAQ:PFWD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Phase Forward (NASDAQ:PFWD)
Historical Stock Chart
From Jul 2023 to Jul 2024